Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Parkinson's disease | R-HSA-1643685 | 0 | helveticoside | 441860 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | helveticoside | 441860 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | helveticoside | 441860 | drug-path |
Vascular smooth muscle contraction | R-HSA-445355 | map04270 | helveticoside | 441860 | drug-path |
Complement and coagulation cascades | R-HSA-114591 | map04610 | helveticoside | 441860 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | helveticoside | 441860 | drug-path |
Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | helveticoside | 441860 | drug-path |
Pathways in cancer | R-HSA-9824443 | map05200 | helveticoside | 441860 | drug-path |
Taste transduction | R-HSA-162582 | map04742 | helveticoside | 441860 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | helveticoside | 441860 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | helveticoside | 441860 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | helveticoside | 441860 | drug-path |
Thyroid cancer | R-HSA-9700206 | map05216 | helveticoside | 441860 | drug-path |
Asthma | R-HSA-444620 | map05310 | helveticoside | 441860 | drug-path |
Jak-STAT signaling pathway | R-HSA-168638 | map04630 | helveticoside | 441860 | drug-path |
Chemokine signaling pathway | R-HSA-168638 | map04062 | helveticoside | 441860 | drug-path |
Cardiac muscle contraction | R-HSA-397014 | map04260 | helveticoside | 441860 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | helveticoside | 441860 | drug-path |
Proteasome | R-HSA-68819 | map03050 | helveticoside | 441860 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | helveticoside | 441860 | drug-path |